美国 · 股市与财经 · The Motley Fool
Eli Lilly's weight loss drug business
And this spring, Lilly won regulatory approval for Foundayo. All three are part of a class of drugs known as GLP-1. These products interact with hormonal pathways involved in…
在 The Motley Fool 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.fool.com)



